Cyclobenzaprine Hydrochloride
Product Images NDC 61919-544

2 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 61919-544). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label 2)

Image Description (Label 2)
The image shows a yellow and white pharmaceutical label for Cyclobenzaprine Hydrochloride 5 mg tablets, 60 count. It states it is a generic version of Flexeril and each tablet contains Cyclobenzaprine HCL USP 5 mg. The label includes directions, caution statements, and storage instructions. The product is packaged and distributed by Direct Rx in Alpharetta, GA. The NDC number 61919-544-60 appears prominently on the label.*
FDA Label Image

Image Description (Module)

Image Description (Module)
Chemical structure of cyclobenzaprine hydrochloride showing the molecular arrangement and connectivity of the compound's atoms and functional groups in a two-dimensional diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.